Please login to bookmark Close
Owners of units in Sydney’s Opal Tower have filed a lawsuit against the NSW Government and builder Icon after allegedly discovering more than 500 additional defects in the troubled building.
Crippled by COVID-19, swimwear brand Seafolly enters administration
Please login to bookmark Close
Citing the “crippling financial impact” of the coronavirus pandemic, Australian swimwear company Seafolly has become the latest fashion retailer to enter voluntary administration.
Court tosses appeal over botched $1.4B Babcock & Brown acquisition
Please login to bookmark Close
A private investment fund has failed again in its bid for damages from collapsed global advisory firm Babcock & Brown over a botched $1.4B acquisition of a US-based laundry equipment provider.
Sequenom’s ‘incorporeal’ prenatal genetic test unpatentable, Ariosa tells Full Court
Please login to bookmark Close
Ariosa Diagnostics is fighting to revoke a patent for noninvasive prenatal test owned by Sequenom, arguing it merely describes how to extract “incorporeal” genetic information that is naturally found within the DNA of an unborn foetus.
Judge scolds law firms behind competing Boral class actions
Please login to bookmark Close
A judge has scolded the law firms behind competing shareholder class actions against Boral for delaying progress of the proceedings, but may wait until the High Court’s ruling on the AMP class action beauty parade before deciding which of three potential class actions should move forward.
Brexit, COVID-19 no reason to alter security terms in Gladstone Ports class action, judge says
Please login to bookmark Close
A judge has rejected claims by Gladstone Ports Corporation that security for costs in a $100 million class action by commercial fishing operators should not be paid through a London-based insurer because of the impact of Brexit and COVID-19.
Janssen files lawsuit to block generic version of HIV drug
Please login to bookmark Close
Drug maker Janssen has fired off a lawsuit against Juno Pharmaceuticals for allegedly threatening to infringe a patent for its HIV drug Prezista with a generic version of the drug, one year after fending off generic competition from a different drug maker.
Government hit with $2.9M judgment in live export class action
Please login to bookmark Close
The lead applicant in a class action against the Federal Government over its total ban on live cattle exports to Indonesia in 2011 has been awarded $2.9 million, potentially exposing the government to hundreds of millions of dollars in damages.
Paternity leave grows in popularity as law firm policies, attitudes shift
Please login to bookmark Close
Law firms are increasingly encouraging men to take paternity leave, with benefits to both the well being of staff, and the bottom line.
Heydon scandal prompts call for harassment law reform
Please login to bookmark Close
Australia’s peak legal body has called for amendments to sex discrimination laws to better protect women against workplace harassment by judges and barristers, and has urged the Morrison government to establish an independent commission to deal with complaints against the judiciary.